|
JP2014227379A
|
|
Agents against cognitive function disorder
|
|
JP2014227380A
|
|
Antidepressant
|
|
US2015119574A1
|
|
Method for producing sepiapterin and tetrahydrolactoylpterin
|
|
JP2010241792A
|
|
Lipase inhibitor, and food and drink
|
|
WO2009047902A1
|
|
Method for producing pteridine compound and method for producing l-biopterin
|
|
JP2009298754A
|
|
Method for producing r-sapropterin or salt thereof
|
|
JP2009298727A
|
|
Method for producing biaryl compound
|
|
JP2009292726A
|
|
Method for producing hydrazone compounds
|
|
BRPI0609421A2
|
|
process for producing hydrazone derivatives
|
|
MX2007013451A
|
|
Method for producing hydrazone derivatives.
|
|
CA2604818A1
|
|
Method for producing alpha form crystals of sapropterin hydrochloride
|
|
MX2007012846A
|
|
Method for producing alpha form crystals of sapropterin hydrochloride.
|
|
JP2007246429A
|
|
Lipase inhibitor, and food and drink
|
|
JP2006290822A
|
|
Method for producing miroesterol
|
|
JP2006290765A
|
|
Method for producing 7-alkyl-10-hydroxycamptothecin
|
|
US2006142573A1
|
|
Method for producing L-biopterin
|
|
JP2006069956A
|
|
Method for producing 2-(5-methyl-2-phenyloxazol-4-yl)acetic acid ester
|
|
JP2006069957A
|
|
Method for producing (5-methyl-2-phenyloxazol-4-yl)methanol
|
|
JP2006008639A
|
|
Method for producing (4r) or (4s)-4-isopropyl-5,5-diaryl-2-oxazolidinone
|
|
JP2005320281A
|
|
Promotor of insulin secretion and food and drink
|
